• Q-VD-OPh and the Logic of Anastasis Assays

  2026-09-01

  Q-VD-OPh is a cell-permeable pan-caspase inhibitor that can do more than improve apoptosis assay consistency. This guide explains how to use inhibitor timing, recovery measurements, and kinome-screen insights to distinguish blocked apoptosis from true post-caspase survival.

• SU6656 for iPSC Platelet Polyploidization

  2026-09-01

  SU6656 offers a practical route for probing Src-dependent cytokinesis control during megakaryocyte maturation and platelet production. Its separate endothelial and tumor-vessel activity also supports carefully designed cancer research workflows, including evaluation as a radiotherapy sensitizer.

• Cl-Amidine Workflows for PAD4 and NET Research

  2026-08-31

  Cl-Amidine enables a practical causality test for PAD4-dependent histone citrullination and neutrophil extracellular trap formation. This guide connects concentration planning, orthogonal NET readouts, CML models, cancer research, rheumatoid arthritis research, and a septic shock murine model while emphasizing formulation and assay controls.

• AP1903 for Reliable FKBP Assays

  2026-08-31

  Learn how AP1903 (SKU B4168) supports controlled protein activation, apoptosis pathway research, and conditional cell ablation in engineered cell systems. This scenario-based guide covers assay design, expression control, formulation, interpretation, and practical product selection.

• Verbascoside for PKC/NF-κB Signaling Studies

  2026-08-30

  Verbascoside is a practical PKC/NF-κB inhibitor for connecting osteoclast differentiation assays with inflammation-focused signaling experiments. This workflow uses its benchmark activity in RANKL-treated macrophage models while showing how to test, rather than assume, relevance to TMJ neuroinflammation.

• From C. auris Biology to Better Cell Assays

  2026-08-29

  How mechanistic insight from Candidozyma auris research can guide more reproducible cell-based phenotyping, with practical strategy for using Crystal Violet Staining Solution in proliferation, migration, invasion, and colony formation workflows.

• LY-411575 Gamma-Secretase Inhibitor Workflows

  2026-08-28

  LY-411575 enables coordinated measurement of amyloid beta generation and Notch cleavage, making it useful for both Alzheimer’s disease research and pathway-focused cancer research. This guide translates its subnanomolar activity into practical cell, conditioned-media, and immune-microenvironment workflows, with controls for separating target engagement from toxicity.

• Pepstatin A for Protease Research

  2026-08-28

  Pepstatin A is a practical aspartic protease inhibitor for separating cathepsin D, viral protease, renin, and pepsin biology from unrelated proteolytic pathways. Its strongest value is experimental discrimination: combined with lysosomal imaging and orthogonal cell-death readouts, it can reveal whether an observed phenotype depends on an aspartic protease rather than serving as a nonspecific substitute for cathepsin B inhibition.

• From Cy3 Signal to Translational Antibody Insight

  2026-08-27

  Translational antibody research depends on more than binding curves: it requires detection strategies that preserve biological context, support reproducible comparisons, and scale across assay formats. This thought-leadership article connects orthopoxvirus antibody discovery with practical use of a Cy3 conjugated secondary antibody for mechanistic validation and translational decision-making.

• Protease Inhibitor Cocktail for Plant Signaling

  2026-08-27

  Learn how a Protease Inhibitor Cocktail preserves plant signaling proteins and post-translational states during extraction. This decision-focused guide applies the NSP2–MYB40 symbiosis study to Western blotting, co-immunoprecipitation, kinase assays, and plant protein workflow design.

• Dexamethasone: A Glucocorticoid Anti-inflammatory Workflow

  2026-08-26

  Dexamethasone (DHAP) provides a practical benchmark for separating broad anti-inflammatory activity from cytotoxicity in macrophage, stem-cell, osteosarcoma, lymphoblastic, and neuroinflammation assays. This workflow pairs solvent-aware handling with dose-response controls and translates a rosemary-root discovery study into reproducible assay choices.

• Urolithin A Workflows for Liver Fibrosis Research

  2026-08-26

  Build mitochondrial quality-control assays around Urolithin A while separating direct evidence from testable hypotheses in hepatic stellate cells. This workflow connects mitophagy, respiration, glutamine metabolism, and fibrosis-relevant readouts without treating one pathway as a surrogate for another.

• Fludarabine: A Decision Framework for Assay Design

  2026-08-25

  Fludarabine is a DNA synthesis inhibitor whose enzyme-level activity can be translated into more informative oncology assays. This guide connects replication blockade, apoptosis readouts, and genotype-aware model selection while defining practical handling parameters.

• Betulinic Acid Protects Against Cyclophosphamide Liver Injur

  2026-08-25

  This 2025 Environmental Toxicology study links betulinic acid protection against cyclophosphamide-induced liver injury to coordinated control of NRF2 antioxidant signaling, ERK–MAPK activity, mitochondrial dynamics, and apoptosis. Its PD98059 intervention strengthens the interpretation that ERK-mediated mitochondrial apoptosis is an important mechanistic component, while also highlighting the limits of extrapolating pharmacological pathway inhibition from mice to human therapy.

• Antipyrine in Translational BBB Research

  2026-08-24

  Antipyrine can serve as a practical translational anchor between pain and fever biology, pharmacokinetic studies, and modern blood-brain barrier workflows. This article explains how to use 1,5-dimethyl-2-phenylpyrazol-3-one strategically in mechanistic assays without overstating what permeability data can prove.

8597 records 1/574 page Next 12345 下5页 Last page